{"nct_id":"NCT06937099","title":"Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight","status":"RECRUITING","status_verified_date":"2025-10","start_date":"2025-06-26","start_date_type":"ACTUAL","primary_completion_date":"2028-05","primary_completion_date_type":"ESTIMATED","completion_date":"2028-05","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["LLY"]}